ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

Introduction of Orbital Atherectomy in Canada Expands Treatment Options for Patients with Complex Coronary Artery Disease Dr. Kalra said, “Patients with calcific coronary artery disease can have poor ...

Please provide your email address to receive an email when new articles are posted on . Orbital atherectomy was no better than balloon angioplasty for treatment of certain severely calcified coronary ...

Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients undergo cardiac stenting procedures does not improve outcomes, a Mount Sinai-led ...

ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI), announced new one-year data and an economic analysis from its ORBIT II coronary study in a late-breaking presentation at the 2014 ...

Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients undergo cardiac stenting procedures does not improve outcomes, a Mount Sinai-led ...

SAN FRANCISCO — The interventional answer to heavily calcified coronary lesions could reside in a balloon catheter that blasts calcifications with bursts of acoustic energy, suggests an early-stage ...

CHICAGO, March 4, 2020 /PRNewswire/ -- According to Arizton's recent research report, Atherectomy Devices Market - Global Outlook and Forecast 2020-2025 is expected to grow at a CAGR of approximately ...

ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...